Report
downloadPipeline
DasKloster 1000-01 - Pulmonary Arterial Hypertension (PAH)
DasKloster 0112-01 - Sarcoidosis
DasKloster 1001-01 - Idiopathic Pulmonary Fibrosis (IPF)
DasKloster 1000–04 - Acute Respiratory Distress Syndrome (ARDS/ALI)
DasKloster 0210-01 - Chronic Beryllium Disease (CBD)
Das Kloster 0141-01 - Acute Respiratory Distress Syndrome (ARDS/ALI)
DasKloster 0249-01 - Drug Resistant Tuberculosis
DasKloster 0014-01 - Hepatitis B Virus induced Hepatocellular Carcinoma
73 In Development - Target not disclosed
Product Pipeline
Related Links
ProductsDevelopment PipelineNews and Press ArchiveBoard of DirectorsMondobiotech Rss FeedsDownloads
Contact Us:
Investor Relations
Investor & External Relations
Mondobiotech Holding AG
Das Kloster
Mürgstrasse 18
CH-6370 Stans
Switzerland
T +41 840 200 010
F +41 840 200 011
investor@mondobiotech.com
Mondobiotech Holding AG
Das Kloster
Mürgstrasse 18
CH-6370 Stans
Switzerland
T +41 840 200 010
F +41 840 200 011
investor@mondobiotech.com
- Mondobiotech
- Fast fact
- Overview
- Milestones
- Board of Directors
- Management
- Location
- Products
- Product Overview
- Types of products
- Pipeline
- Rare Diseases
- About Rare Diseases
- Patient and Families
- Rare Diseases List
- Media Archive
- Investor
- Financial Information
- Key Information
- Corporate Governance
- Appointments
- Partnership
- Pipeline
- Science
- Pipeline
- Product Overview
- Research Vision
Copyright 2010 mondoBIOTECH holding AG, all rights reserved.
Terms and Conditions |
Privacy Policy |
Sitemap |
Contact Us |
Website Feedback |
FAQ |
RSS